Ultrasound cancer treatment, supported by Li Ka-shing, gains traction in Asia: US expert

Quick Summary:

Focused ultrasound, backed by Li Ka-shing, is emerging as a non-invasive, commercially viable cancer treatment, attracting significant investments.

The Hong Kong billionaire’s charity last month announced that it would donate two more machines to the city’s hospitals, sponsor the treatment of 20 patients and support the training of six doctors and radiologists by HistoSonics.

The company, which completed a US$102 million series D financing round last month, counts a unit of healthcare giant Johnson & Johnson as one of its investors.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Eric Ng

Category: Technology

Markets: Hong Kong

Topics: Ultrasound Clinical Treatments Investors Treatment According Histosonics Hong Number Kong Focused

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-29 @ 14:00:19 (4 hours ago)

News Timezone: GMT +8:00

News Source URL: scmp.com

Language: English

Article Length: 225 words

Reading Time: 2 minutes read

Sentences: 6 lines

Sentence Length: 38 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © SCMP

News ID: 22765309

View Article Analysis

About SCMP

Main Topics: Technology

Official Website: scmp.com

Update Frequency: 3 posts per day

Year Established: 1903

Headquarters: Hong Kong

News Last Updated: 2 hours ago

Coverage Areas: Hong Kong

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #41

Publisher Details

Frequently Asked Questions